Europe Genitourinary Drugs Market Research Report Forecast 2017 to 2022

September 2017 | 107 pages | ID: EE1A326736DEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Genitourinary Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Genitourinary Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Genitourinary Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Genitourinary Drugs Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Astellas
Pfizer
GlaxoSmithKline
Eli Lilly
Bayer AG
Merck
Abbott Laboratories
Bristol-Myers Squibb
Genentech

Europe Genitourinary Drugs Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Genitourinary Drugs Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 GENITOURINARY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Genitourinary Drugs
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Genitourinary Drugs Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Genitourinary Drugs (2012-2022)
  1.5.1 Europe Genitourinary Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Europe Genitourinary Drugs Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON GENITOURINARY DRUGS INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 GENITOURINARY DRUGS MANUFACTURING COST ANALYSIS

3.1 Genitourinary Drugs Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Genitourinary Drugs

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Genitourinary Drugs Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE GENITOURINARY DRUGS MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Genitourinary Drugs Market Competition by Manufacturers
  5.1.1 Europe Genitourinary Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Genitourinary Drugs Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Genitourinary Drugs (Volume and Value) by Type
  5.2.1 Europe Genitourinary Drugs Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
5.3 Europe Genitourinary Drugs (Volume and Value) by Countries
  5.3.1 Europe Genitourinary Drugs Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Genitourinary Drugs Revenue and Market Share by Countries (2012-2017)
5.4 Europe Genitourinary Drugs (Volume) by Application

6 GERMANY GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Genitourinary Drugs Sales and Value (2012-2017)
  6.1.1 Germany Genitourinary Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Germany Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Genitourinary Drugs Sales Price Trend (2012-2017)
6.2 Germany Genitourinary Drugs Sales and Market Share by Manufacturers
6.3 Germany Genitourinary Drugs Sales and Market Share by Type
6.4 Germany Genitourinary Drugs Sales and Market Share by Application

7 FRANCE GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 France Genitourinary Drugs Sales and Value (2012-2017)
  7.1.1 France Genitourinary Drugs Sales and Growth Rate (2012-2017)
  7.1.2 France Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 France Genitourinary Drugs Sales Price Trend (2012-2017)
7.2 France Genitourinary Drugs Sales and Market Share by Manufacturers
7.3 France Genitourinary Drugs Sales and Market Share by Type
7.4 France Genitourinary Drugs Sales and Market Share by Application

8 UK GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 UK Genitourinary Drugs Sales and Value (2012-2017)
  8.1.1 UK Genitourinary Drugs Sales and Growth Rate (2012-2017)
  8.1.2 UK Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 UK Genitourinary Drugs Sales Price Trend (2012-2017)
8.2 UK Genitourinary Drugs Sales and Market Share by Manufacturers
8.3 UK Genitourinary Drugs Sales and Market Share by Type
8.4 UK Genitourinary Drugs Sales and Market Share by Application

9 RUSSIA GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Genitourinary Drugs Sales and Value (2012-2017)
  9.1.1 Russia Genitourinary Drugs Sales and Growth Rate (2012-2017)
  9.1.2 Russia Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Genitourinary Drugs Sales Price Trend (2012-2017)
9.2 Russia Genitourinary Drugs Sales and Market Share by Manufacturers
9.3 Russia Genitourinary Drugs Sales and Market Share by Type
9.4 Russia Genitourinary Drugs Sales and Market Share by Application

10 ITALY GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Genitourinary Drugs Sales and Value (2012-2017)
  10.1.1 Italy Genitourinary Drugs Sales and Growth Rate (2012-2017)
  10.1.2 Italy Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Genitourinary Drugs Sales Price Trend (2012-2017)
10.2 Italy Genitourinary Drugs Sales and Market Share by Manufacturers
10.3 Italy Genitourinary Drugs Sales and Market Share by Type
10.4 Italy Genitourinary Drugs Sales and Market Share by Application

11 SPAIN GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Genitourinary Drugs Sales and Value (2012-2017)
  11.1.1 Spain Genitourinary Drugs Sales and Growth Rate (2012-2017)
  11.1.2 Spain Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Genitourinary Drugs Sales Price Trend (2012-2017)
11.2 Spain Genitourinary Drugs Sales and Market Share by Manufacturers
11.3 Spain Genitourinary Drugs Sales and Market Share by Type
11.4 Spain Genitourinary Drugs Sales and Market Share by Application

12 BENELUX GENITOURINARY DRUGS (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Genitourinary Drugs Sales and Value (2012-2017)
  12.1.1 Benelux Genitourinary Drugs Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Genitourinary Drugs Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Genitourinary Drugs Sales Price Trend (2012-2017)
12.2 Benelux Genitourinary Drugs Sales and Market Share by Manufacturers
12.3 Benelux Genitourinary Drugs Sales and Market Share by Type
12.4 Benelux Genitourinary Drugs Sales and Market Share by Application

13 EUROPE GENITOURINARY DRUGS MANUFACTURERS ANALYSIS

13.1 Astellas
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Pfizer
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 GlaxoSmithKline
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Eli Lilly
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Bayer AG
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Merck
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Abbott Laboratories
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bristol-Myers Squibb
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Genentech
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE GENITOURINARY DRUGS MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Genitourinary Drugs Market Forecast by Type (2017-2022)
15.9 Europe Genitourinary Drugs Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure Europe Sales Market Share of Genitourinary Drugs by Type in 2016
Table Application of Genitourinary Drugs
Figure Europe Sales Market Share of Genitourinary Drugs by Application in 2016
Figure Germany Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure France Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure UK Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Genitourinary Drugs Sales and Growth Rate (2012-2022)
Figure Europe Genitourinary Drugs Revenue and Growth Rate (2012-2022)
Table Europe Genitourinary Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Genitourinary Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genitourinary Drugs Sales Share by Manufacturers
Figure 2016 Genitourinary Drugs Sales Share by Manufacturers
Table Europe Genitourinary Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Genitourinary Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Genitourinary Drugs Revenue Share by Manufacturers
Table 2016 Europe Genitourinary Drugs Revenue Share by Manufacturers
Table Europe Genitourinary Drugs Sales and Market Share by Type (2012-2017)
Table Europe Genitourinary Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Europe Genitourinary Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Genitourinary Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Genitourinary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Type (2012-2017)
Figure Europe Genitourinary Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Genitourinary Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Genitourinary Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Countries (2012-2017)
Table Europe Genitourinary Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Genitourinary Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Genitourinary Drugs by Countries (2012-2017)
Table Europe Genitourinary Drugs Sales and Market Share by Application (2012-2017)
Table Europe Genitourinary Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Genitourinary Drugs by Application (2012-2017)
Figure Germany Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Germany Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Genitourinary Drugs Sales Price Trend (2012-2017)
Table Germany Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Genitourinary Drugs Sales by Type (2015 and 2016)
Table Germany Genitourinary Drugs Market Share by Type (2015 and 2016)
Table Germany Genitourinary Drugs Sales by Application (2015 and 2016)
Table Germany Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure France Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure France Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure France Genitourinary Drugs Sales Price Trend (2012-2017)
Table France Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table France Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table France Genitourinary Drugs Sales by Type (2015 and 2016)
Table France Genitourinary Drugs Market Share by Type (2015 and 2016)
Table France Genitourinary Drugs Sales by Application (2015 and 2016)
Table France Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure UK Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure UK Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure UK Genitourinary Drugs Sales Price Trend (2012-2017)
Table UK Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table UK Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Genitourinary Drugs Sales by Type (2015 and 2016)
Table UK Genitourinary Drugs Market Share by Type (2015 and 2016)
Table UK Genitourinary Drugs Sales by Application (2015 and 2016)
Table UK Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure Russia Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Russia Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Genitourinary Drugs Sales Price Trend (2012-2017)
Table Russia Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Genitourinary Drugs Sales by Type (2015 and 2016)
Table Russia Genitourinary Drugs Market Share by Type (2015 and 2016)
Table Russia Genitourinary Drugs Sales by Application (2015 and 2016)
Table Russia Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure Italy Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Italy Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Genitourinary Drugs Sales Price Trend (2012-2017)
Table Italy Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Genitourinary Drugs Sales by Type (2015 and 2016)
Table Italy Genitourinary Drugs Market Share by Type (2015 and 2016)
Table Italy Genitourinary Drugs Sales by Application (2015 and 2016)
Table Italy Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure Spain Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Spain Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Genitourinary Drugs Sales Price Trend (2012-2017)
Table Spain Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Genitourinary Drugs Sales by Type (2015 and 2016)
Table Spain Genitourinary Drugs Market Share by Type (2015 and 2016)
Table Spain Genitourinary Drugs Sales by Application (2015 and 2016)
Table Spain Genitourinary Drugs Market Share by Application (2015 and 2016)
Figure Benelux Genitourinary Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Genitourinary Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Genitourinary Drugs Sales Price Trend (2012-2017)
Table Benelux Genitourinary Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Genitourinary Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Genitourinary Drugs Sales by Type (2015 and 2016)
Table Benelux Genitourinary Drugs Market Share by Type (2015 and 2016)
Table Benelux Genitourinary Drugs Sales by Application (2015 and 2016)
Table Benelux Genitourinary Drugs Market Share by Application (2015 and 2016)
Table Astellas Basic Information List
Table Astellas Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Genitourinary Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Genitourinary Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Genitourinary Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Genitourinary Drugs Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer AG Genitourinary Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Genitourinary Drugs Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories Genitourinary Drugs Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Genitourinary Drugs Sales Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Genitourinary Drugs Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genitourinary Drugs
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Genitourinary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Genitourinary Drugs Major Manufacturers in 2016
Table Major Buyers of Genitourinary Drugs
Table Distributors/Traders List
Figure Germany Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Genitourinary Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Genitourinary Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Genitourinary Drugs Sales Forecast by Type (2017-2022)
Table Europe Genitourinary Drugs Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Astellas
Pfizer
GlaxoSmithKline
Eli Lilly
Bayer AG
Merck
Abbott Laboratories
Bristol-Myers Squibb
Genentech
Roche
Amgen
Botex